Post-transcriptional regulation in metabolic diseases

References

• Permutt MA, Wasson J, Cox N. Genetic epidemiology of diabetes. J Clin Invest 2005; 115:1431 - 9; http://dx.doi.org/10.1172/JCI24758; PMID: 15931378
   PubMed Web of Science ®Google Scholar
• Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E, et al. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med 1993; 329:1988 - 92; http://dx.doi.org/10.1056/NEJM199312303292703; PMID: 8247074
   PubMed Web of Science ®Google Scholar
• Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001; 414:799 - 806; http://dx.doi.org/10.1038/414799a; PMID: 11742412
   PubMed Web of Science ®Google Scholar
• Anderson JW, Kendall CW, Jenkins DJ. Importance of weight management in type 2 diabetes: review with meta-analysis of clinical studies. J Am Coll Nutr 2003; 22:331 - 9; PMID: 14559925
   PubMed Web of Science ®Google Scholar
• Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005; 433:769 - 73; http://dx.doi.org/10.1038/nature03315; PMID: 15685193
   PubMed Web of Science ®Google Scholar
• Chekulaeva M, Filipowicz W. Mechanisms of miRNA-mediated post-transcriptional regulation in animal cells. Curr Opin Cell Biol 2009; 21:452 - 60; http://dx.doi.org/10.1016/j.ceb.2009.04.009; PMID: 19450959
   PubMed Web of Science ®Google Scholar
• Fabian MR, Sonenberg N, Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 2010; 79:351 - 79; http://dx.doi.org/10.1146/annurev-biochem-060308-103103; PMID: 20533884
   PubMed Web of Science ®Google Scholar
• Vasudevan S, Tong Y, Steitz JA. Switching from repression to activation: microRNAs can up-regulate translation. Science 2007; 318:1931 - 4; http://dx.doi.org/10.1126/science.1149460; PMID: 18048652
   PubMed Web of Science ®Google Scholar
• Ørom UA, Nielsen FC, Lund AH. MicroRNA-10a binds the 5’UTR of ribosomal protein mRNAs and enhances their translation. Mol Cell 2008; 30:460 - 71; http://dx.doi.org/10.1016/j.molcel.2008.05.001; PMID: 18498749
   PubMed Web of Science ®Google Scholar
• Henke JI, Goergen D, Zheng J, Song Y, Schüttler CG, Fehr C, et al. microRNA-122 stimulates translation of hepatitis C virus RNA. EMBO J 2008; 27:3300 - 10; http://dx.doi.org/10.1038/emboj.2008.244; PMID: 19020517
   PubMed Web of Science ®Google Scholar
• Abdelmohsen K, Kuwano Y, Kim HH, Gorospe M. Posttranscriptional gene regulation by RNA-binding proteins during oxidative stress: implications for cellular senescence. Biol Chem 2008; 389:243 - 55; http://dx.doi.org/10.1515/BC.2008.022; PMID: 18177264
   PubMed Web of Science ®Google Scholar
• Lunde BM, Moore C, Varani G. RNA-binding proteins: modular design for efficient function. Nat Rev Mol Cell Biol 2007; 8:479 - 90; http://dx.doi.org/10.1038/nrm2178; PMID: 17473849
   PubMed Web of Science ®Google Scholar
• Lee EK, Gorospe M. Coding region: the neglected post-transcriptional code. RNA Biol 2011; 8:44 - 8; http://dx.doi.org/10.4161/rna.8.1.13863; PMID: 21289484
   PubMed Web of Science ®Google Scholar
• Abdelmohsen K, Tominaga K, Lee EK, Srikantan S, Kang MJ, Kim MM, et al. Enhanced translation by Nucleolin via G-rich elements in coding and non-coding regions of target mRNAs. Nucleic Acids Res 2011; 39:8513 - 30; http://dx.doi.org/10.1093/nar/gkr488; PMID: 21737422
   PubMed Web of Science ®Google Scholar
• Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S, et al. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 1998; 391:900 - 4; http://dx.doi.org/10.1038/36116; PMID: 9495343
   PubMed Web of Science ®Google Scholar
• Kulkarni RN, Brüning JC, Winnay JN, Postic C, Magnuson MA, Kahn CR. Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 1999; 96:329 - 39; http://dx.doi.org/10.1016/S0092-8674(00)80546-2; PMID: 10025399
   PubMed Web of Science ®Google Scholar
• Kulkarni RN, Winnay JN, Daniels M, Brüning JC, Flier SN, Hanahan D, et al. Altered function of insulin receptor substrate-1-deficient mouse islets and cultured beta-cell lines. J Clin Invest 1999; 104:R69 - 75; http://dx.doi.org/10.1172/JCI8339; PMID: 10606633
   PubMed Web of Science ®Google Scholar
• Uchida T, Nakamura T, Hashimoto N, Matsuda T, Kotani K, Sakaue H, et al. Deletion of Cdkn1b ameliorates hyperglycemia by maintaining compensatory hyperinsulinemia in diabetic mice. Nat Med 2005; 11:175 - 82; http://dx.doi.org/10.1038/nm1187; PMID: 15685168
   PubMed Web of Science ®Google Scholar
• Ebina Y, Ellis L, Jarnagin K, Edery M, Graf L, Clauser E, et al. The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signalling. Cell 1985; 40:747 - 58; http://dx.doi.org/10.1016/0092-8674(85)90334-4; PMID: 2859121
   PubMed Web of Science ®Google Scholar
• Ullrich A, Bell JR, Chen EY, Herrera R, Petruzzelli LM, Dull TJ, et al. Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Nature 1985; 313:756 - 61; http://dx.doi.org/10.1038/313756a0; PMID: 2983222
   PubMed Web of Science ®Google Scholar
• Michael MD, Kulkarni RN, Postic C, Previs SF, Shulman GI, Magnuson MA, et al. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell 2000; 6:87 - 97; PMID: 10949030
   PubMed Web of Science ®Google Scholar
• Fernández AM, Kim JK, Yakar S, Dupont J, Hernandez-Sanchez C, Castle AL, et al. Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes. Genes Dev 2001; 15:1926 - 34; http://dx.doi.org/10.1101/gad.908001; PMID: 11485987
   PubMed Web of Science ®Google Scholar
• Miyake K, Ogawa W, Matsumoto M, Nakamura T, Sakaue H, Kasuga M. Hyperinsulinemia, glucose intolerance, and dyslipidemia induced by acute inhibition of phosphoinositide 3-kinase signaling in the liver. J Clin Invest 2002; 110:1483 - 91; PMID: 12438446
   PubMed Web of Science ®Google Scholar
• Poy MN, Eliasson L, Krutzfeldt J, Kuwajima S, Ma X, Macdonald PE, et al. A pancreatic islet-specific microRNA regulates insulin secretion. Nature 2004; 432:226 - 30; http://dx.doi.org/10.1038/nature03076; PMID: 15538371
   PubMed Web of Science ®Google Scholar
• El Ouaamari A, Baroukh N, Martens GA, Lebrun P, Pipeleers D, van Obberghen E. miR-375 targets 3′-phosphoinositide-dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic beta-cells. Diabetes 2008; 57:2708 - 17; http://dx.doi.org/10.2337/db07-1614; PMID: 18591395
   PubMed Web of Science ®Google Scholar
• Keller DM, McWeeney S, Arsenlis A, Drouin J, Wright CV, Wang H, et al. Characterization of pancreatic transcription factor Pdx-1 binding sites using promoter microarray and serial analysis of chromatin occupancy. J Biol Chem 2007; 282:32084 - 92; http://dx.doi.org/10.1074/jbc.M700899200; PMID: 17761679
   PubMed Web of Science ®Google Scholar
• Zhao E, Keller MP, Rabaglia ME, Oler AT, Stapleton DS, Schueler KL, et al. Obesity and genetics regulate microRNAs in islets, liver, and adipose of diabetic mice. Mamm Genome 2009; 20:476 - 85; http://dx.doi.org/10.1007/s00335-009-9217-2; PMID: 19727952
   PubMed Web of Science ®Google Scholar
• Poy MN, Hausser J, Trajkovski M, Braun M, Collins S, Rorsman P, et al. miR-375 maintains normal pancreatic alpha- and beta-cell mass. Proc Natl Acad Sci U S A 2009; 106:5813 - 8; http://dx.doi.org/10.1073/pnas.0810550106; PMID: 19289822
   PubMed Web of Science ®Google Scholar
• Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, et al. RAS is regulated by the let-7 microRNA family. Cell 2005; 120:635 - 47; http://dx.doi.org/10.1016/j.cell.2005.01.014; PMID: 15766527
   PubMed Web of Science ®Google Scholar
• Lee YS, Dutta A. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev 2007; 21:1025 - 30; http://dx.doi.org/10.1101/gad.1540407; PMID: 17437991
   PubMed Web of Science ®Google Scholar
• Mayr C, Hemann MT, Bartel DP. Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 2007; 315:1576 - 9; http://dx.doi.org/10.1126/science.1137999; PMID: 17322030
   PubMed Web of Science ®Google Scholar
• Kumar MS, Erkeland SJ, Pester RE, Chen CY, Ebert MS, Sharp PA, et al. Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc Natl Acad Sci U S A 2008; 105:3903 - 8; http://dx.doi.org/10.1073/pnas.0712321105; PMID: 18308936
   PubMed Web of Science ®Google Scholar
• Heo I, Joo C, Cho J, Ha M, Han J, Kim VN. Lin28 mediates the terminal uridylation of let-7 precursor MicroRNA. Mol Cell 2008; 32:276 - 84; http://dx.doi.org/10.1016/j.molcel.2008.09.014; PMID: 18951094
   PubMed Web of Science ®Google Scholar
• Viswanathan SR, Daley GQ, Gregory RI. Selective blockade of microRNA processing by Lin28. Science 2008; 320:97 - 100; http://dx.doi.org/10.1126/science.1154040; PMID: 18292307
   PubMed Web of Science ®Google Scholar
• Viswanathan SR, Powers JT, Einhorn W, Hoshida Y, Ng TL, Toffanin S, et al. Lin28 promotes transformation and is associated with advanced human malignancies. Nat Genet 2009; 41:843 - 8; http://dx.doi.org/10.1038/ng.392; PMID: 19483683
   PubMed Web of Science ®Google Scholar
• Zhu H, Shyh-Chang N, Segrè AV, Shinoda G, Shah SP, Einhorn WS, et al, DIAGRAM Consortium, MAGIC Investigators. The Lin28/let-7 axis regulates glucose metabolism. Cell 2011; 147:81 - 94; http://dx.doi.org/10.1016/j.cell.2011.08.033; PMID: 21962509
   PubMed Web of Science ®Google Scholar
• Guay C, Roggli E, Nesca V, Jacovetti C, Regazzi R. Diabetes mellitus, a microRNA-related disease?. Transl Res 2011; 157:253 - 64; http://dx.doi.org/10.1016/j.trsl.2011.01.009; PMID: 21420036
   PubMed Web of Science ®Google Scholar
• Trajkovski M, Hausser J, Soutschek J, Bhat B, Akin A, Zavolan M, et al. MicroRNAs 103 and 107 regulate insulin sensitivity. Nature 2011; 474:649 - 53; http://dx.doi.org/10.1038/nature10112; PMID: 21654750
   PubMed Web of Science ®Google Scholar
• Jordan SD, Krüger M, Willmes DM, Redemann N, Wunderlich FT, Brönneke HS, et al. Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism. Nat Cell Biol 2011; 13:434 - 46; http://dx.doi.org/10.1038/ncb2211; PMID: 21441927
   PubMed Web of Science ®Google Scholar
• Esau C, Kang X, Peralta E, Hanson E, Marcusson EG, Ravichandran LV, et al. MicroRNA-143 regulates adipocyte differentiation. J Biol Chem 2004; 279:52361 - 5; http://dx.doi.org/10.1074/jbc.C400438200; PMID: 15504739
   PubMed Web of Science ®Google Scholar
• Xie H, Lim B, Lodish HF. MicroRNAs induced during adipogenesis that accelerate fat cell development are downregulated in obesity. Diabetes 2009; 58:1050 - 7; http://dx.doi.org/10.2337/db08-1299; PMID: 19188425
   PubMed Web of Science ®Google Scholar
• Takanabe R, Ono K, Abe Y, Takaya T, Horie T, Wada H, et al. Up-regulated expression of microRNA-143 in association with obesity in adipose tissue of mice fed high-fat diet. Biochem Biophys Res Commun 2008; 376:728 - 32; http://dx.doi.org/10.1016/j.bbrc.2008.09.050; PMID: 18809385
   PubMed Web of Science ®Google Scholar
• Li S, Chen X, Zhang H, Liang X, Xiang Y, Yu C, et al. Differential expression of microRNAs in mouse liver under aberrant energy metabolic status. J Lipid Res 2009; 50:1756 - 65; http://dx.doi.org/10.1194/jlr.M800509-JLR200; PMID: 19372595
   PubMed Web of Science ®Google Scholar
• Gallagher IJ, Scheele C, Keller P, Nielsen AR, Remenyi J, Fischer CP, et al. Integration of microRNA changes in vivo identifies novel molecular features of muscle insulin resistance in type 2 diabetes. Genome Med 2010; 2:9; http://dx.doi.org/10.1186/gm130; PMID: 20353613
   PubMed Web of Science ®Google Scholar
• Lee EK, Gorospe M. Minireview: posttranscriptional regulation of the insulin and insulin-like growth factor systems. Endocrinology 2010; 151:1403 - 8; http://dx.doi.org/10.1210/en.2009-1123; PMID: 20032049
   PubMed Web of Science ®Google Scholar
• Melkman-Zehavi T, Oren R, Kredo-Russo S, Shapira T, Mandelbaum AD, Rivkin N, et al. miRNAs control insulin content in pancreatic β-cells via downregulation of transcriptional repressors. EMBO J 2011; 30:835 - 45; http://dx.doi.org/10.1038/emboj.2010.361; PMID: 21285947
   PubMed Web of Science ®Google Scholar
• Kulkarni SD, Muralidharan B, Panda AC, Bakthavachalu B, Vindu A, Seshadri V. Glucose-stimulated translation regulation of insulin by the 5′ UTR-binding proteins. J Biol Chem 2011; 286:14146 - 56; http://dx.doi.org/10.1074/jbc.M110.190553; PMID: 21357685
   PubMed Web of Science ®Google Scholar
• Roggli E, Gattesco S, Pautz A, Regazzi R. Involvement of the RNA-binding protein ARE/poly(U)-binding factor 1 (AUF1) in the cytotoxic effects of proinflammatory cytokines on pancreatic beta cells. [Epup ahead of print] Diabetologia 2011; http://dx.doi.org/10.1007/s00125-011-2399-7; PMID: 22159912
   PubMed Web of Science ®Google Scholar
• Tillmar L, Carlsson C, Welsh N. Control of insulin mRNA stability in rat pancreatic islets. Regulatory role of a 3′-untranslated region pyrimidine-rich sequence. J Biol Chem 2002; 277:1099 - 106; http://dx.doi.org/10.1074/jbc.M108340200; PMID: 11696543
   PubMed Web of Science ®Google Scholar
• Tillmar L, Welsh N. Hypoxia may increase rat insulin mRNA levels by promoting binding of the polypyrimidine tract-binding protein (PTB) to the pyrimidine-rich insulin mRNA 3′-untranslated region. Mol Med 2002; 8:263 - 72; PMID: 12359957
   PubMed Web of Science ®Google Scholar
• Knoch KP, Bergert H, Borgonovo B, Saeger HD, Altkrüger A, Verkade P, et al. Polypyrimidine tract-binding protein promotes insulin secretory granule biogenesis. Nat Cell Biol 2004; 6:207 - 14; http://dx.doi.org/10.1038/ncb1099; PMID: 15039777
   PubMed Web of Science ®Google Scholar
• Lee EK, Kim W, Tominaga K, Martindale JL, Yang X, Subaran SS, et al. RNA-binding protein HuD controls insulin translation. Mol Cell 2012; In press http://dx.doi.org/10.1016/j.molcel.2012.01.016; PMID: 22387028
   PubMed Web of Science ®Google Scholar
• Szabo A, Dalmau J, Manley G, Rosenfeld M, Wong E, Henson J, et al. HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal. Cell 1991; 67:325 - 33; http://dx.doi.org/10.1016/0092-8674(91)90184-Z; PMID: 1655278
   PubMed Web of Science ®Google Scholar
• Okano HJ, Darnell RB. A hierarchy of Hu RNA binding proteins in developing and adult neurons. J Neurosci 1997; 17:3024 - 37; PMID: 9096138
   PubMed Web of Science ®Google Scholar
• Grundy SM. Absorption and metabolism of dietary cholesterol. Annu Rev Nutr 1983; 3:71 - 96; http://dx.doi.org/10.1146/annurev.nu.03.070183.000443; PMID: 6357243
   PubMed Web of Science ®Google Scholar
• Brown MS, Goldstein JL. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 1997; 89:331 - 40; http://dx.doi.org/10.1016/S0092-8674(00)80213-5; PMID: 9150132
   PubMed Web of Science ®Google Scholar
• Peet DJ, Janowski BA, Mangelsdorf DJ. The LXRs: a new class of oxysterol receptors. Curr Opin Genet Dev 1998; 8:571 - 5; http://dx.doi.org/10.1016/S0959-437X(98)80013-0; PMID: 9794827
   PubMed Web of Science ®Google Scholar
• Tall AR, Yvan-Charvet L, Terasaka N, Pagler T, Wang N. HDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis. Cell Metab 2008; 7:365 - 75; http://dx.doi.org/10.1016/j.cmet.2008.03.001; PMID: 18460328
   PubMed Web of Science ®Google Scholar
• Schroeder F. Fluorescence probes in metastatic B16 melanoma membranes. Biochim Biophys Acta 1984; 776:299 - 312; http://dx.doi.org/10.1016/0005-2736(84)90219-0; PMID: 6477911
   PubMed Web of Science ®Google Scholar
• Williams KJ, Tabas I. The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol 1995; 15:551 - 61; http://dx.doi.org/10.1161/01.ATV.15.5.551; PMID: 7749869
   PubMed Web of Science ®Google Scholar
• Aikawa M, Libby P. The vulnerable atherosclerotic plaque: pathogenesis and therapeutic approach. Cardiovasc Pathol 2004; 13:125 - 38; http://dx.doi.org/10.1016/S1054-8807(04)00004-3; PMID: 15081469
   PubMed Web of Science ®Google Scholar
• Krützfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, et al. Silencing of microRNAs in vivo with ‘antagomirs’. Nature 2005; 438:685 - 9; http://dx.doi.org/10.1038/nature04303; PMID: 16258535
   PubMed Web of Science ®Google Scholar
• Esau C, Davis S, Murray SF, Yu XX, Pandey SK, Pear M, et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 2006; 3:87 - 98; http://dx.doi.org/10.1016/j.cmet.2006.01.005; PMID: 16459310
   PubMed Web of Science ®Google Scholar
• Elmén J, Lindow M, Silahtaroglu A, Bak M, Christensen M, Lind-Thomsen A, et al. Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Res 2008; 36:1153 - 62; http://dx.doi.org/10.1093/nar/gkm1113; PMID: 18158304
   PubMed Web of Science ®Google Scholar
• Marquart TJ, Allen RM, Ory DS, Baldán A. miR-33 links SREBP-2 induction to repression of sterol transporters. Proc Natl Acad Sci U S A 2010; 107:12228 - 32; http://dx.doi.org/10.1073/pnas.1005191107; PMID: 20566875
   PubMed Web of Science ®Google Scholar
• Rayner KJ, Suárez Y, Dávalos A, Parathath S, Fitzgerald ML, Tamehiro N, et al. MiR-33 contributes to the regulation of cholesterol homeostasis. Science 2010; 328:1570 - 3; http://dx.doi.org/10.1126/science.1189862; PMID: 20466885
   PubMed Web of Science ®Google Scholar
• Dávalos A, Goedeke L, Smibert P, Ramírez CM, Warrier NP, Andreo U, et al. miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling. Proc Natl Acad Sci U S A 2011; 108:9232 - 7; http://dx.doi.org/10.1073/pnas.1102281108; PMID: 21576456
   PubMed Web of Science ®Google Scholar
• Najafi-Shoushtari SH, Kristo F, Li Y, Shioda T, Cohen DE, Gerszten RE, et al. MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science 2010; 328:1566 - 9; http://dx.doi.org/10.1126/science.1189123; PMID: 20466882
   PubMed Web of Science ®Google Scholar
• Gerin I, Clerbaux LA, Haumont O, Lanthier N, Das AK, Burant CF, et al. Expression of miR-33 from an SREBP2 intron inhibits cholesterol export and fatty acid oxidation. J Biol Chem 2010; 285:33652 - 61; http://dx.doi.org/10.1074/jbc.M110.152090; PMID: 20732877
   PubMed Web of Science ®Google Scholar
• Gerin I, Bommer GT, McCoin CS, Sousa KM, Krishnan V, MacDougald OA. Roles for miRNA-378/378* in adipocyte gene expression and lipogenesis. Am J Physiol Endocrinol Metab 2010; 299:E198 - 206; PMID: 20484008
   PubMed Web of Science ®Google Scholar
• Gantt K, Cherry J, Tenney R, Karschner V, Pekala PH. An early event in adipogenesis, the nuclear selection of the CCAAT enhancer-binding protein beta (C/EBPbeta) mRNA by HuR and its translocation to the cytosol. J Biol Chem 2005; 280:24768 - 74; http://dx.doi.org/10.1074/jbc.M502011200; PMID: 15863502
   PubMed Web of Science ®Google Scholar
• Kawagishi H, Wakoh T, Uno H, Maruyama M, Moriya A, Morikawa S, et al. Hzf regulates adipogenesis through translational control of C/EBPalpha. EMBO J 2008; 27:1481 - 90; PMID: 18418387
   PubMed Web of Science ®Google Scholar
• Plaisance V, Abderrahmani A, Perret-Menoud V, Jacquemin P, Lemaigre F, Regazzi R. MicroRNA-9 controls the expression of Granuphilin/Slp4 and the secretory response of insulin-producing cells. J Biol Chem 2006; 281:26932 - 42; http://dx.doi.org/10.1074/jbc.M601225200; PMID: 16831872
   PubMed Web of Science ®Google Scholar
• Sun LL, Jiang BG, Li WT, Zou JJ, Shi YQ, Liu ZM. MicroRNA-15a positively regulates insulin synthesis by inhibiting uncoupling protein-2 expression. Diabetes Res Clin Pract 2011; 91:94 - 100; http://dx.doi.org/10.1016/j.diabres.2010.11.006; PMID: 21146880
   PubMed Web of Science ®Google Scholar
• Roggli E, Britan A, Gattesco S, Lin-Marq N, Abderrahmani A, Meda P, et al. Involvement of microRNAs in the cytotoxic effects exerted by proinflammatory cytokines on pancreatic beta-cells. Diabetes 2010; 59:978 - 86; http://dx.doi.org/10.2337/db09-0881; PMID: 20086228
   PubMed Web of Science ®Google Scholar
• Ruan Q, Wang T, Kameswaran V, Wei Q, Johnson DS, Matschinsky F, et al. The microRNA-21-PDCD4 axis prevents type 1 diabetes by blocking pancreatic beta cell death. Proc Natl Acad Sci U S A 2011; 108:12030 - 5; http://dx.doi.org/10.1073/pnas.1101450108; PMID: 21730150
   PubMed Web of Science ®Google Scholar
• He A, Zhu L, Gupta N, Chang Y, Fang F. Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes. Mol Endocrinol 2007; 21:2785 - 94; http://dx.doi.org/10.1210/me.2007-0167; PMID: 17652184
   PubMed Web of Science ®Google Scholar
• Tang X, Muniappan L, Tang G, Ozcan S. Identification of glucose-regulated miRNAs from pancreatic beta cells reveals a role for miR-30d in insulin transcription. RNA 2009; 15:287 - 93; http://dx.doi.org/10.1261/rna.1211209; PMID: 19096044
   PubMed Web of Science ®Google Scholar
• Lovis P, Roggli E, Laybutt DR, Gattesco S, Yang JY, Widmann C, et al. Alterations in microRNA expression contribute to fatty acid-induced pancreatic beta-cell dysfunction. Diabetes 2008; 57:2728 - 36; http://dx.doi.org/10.2337/db07-1252; PMID: 18633110
   PubMed Web of Science ®Google Scholar
• Lovis P, Gattesco S, Regazzi R. Regulation of the expression of components of the exocytotic machinery of insulin-secreting cells by microRNAs. Biol Chem 2008; 389:305 - 12; http://dx.doi.org/10.1515/BC.2008.026; PMID: 18177263
   PubMed Web of Science ®Google Scholar
• Hennessy E, Clynes M, Jeppesen PB, O’Driscoll L. Identification of microRNAs with a role in glucose stimulated insulin secretion by expression profiling of MIN6 cells. Biochem Biophys Res Commun 2010; 396:457 - 62; http://dx.doi.org/10.1016/j.bbrc.2010.04.116; PMID: 20417623
   PubMed Web of Science ®Google Scholar
• Teleman AA, Maitra S, Cohen SM. Drosophila lacking microRNA miR-278 are defective in energy homeostasis. Genes Dev 2006; 20:417 - 22; http://dx.doi.org/10.1101/gad.374406; PMID: 16481470
   PubMed Web of Science ®Google Scholar
• Kim YJ, Hwang SJ, Bae YC, Jung JS. MiR-21 regulates adipogenic differentiation through the modulation of TGF-beta signaling in mesenchymal stem cells derived from human adipose tissue. Stem Cells 2009; 27:3093 - 102; PMID: 19816956
   PubMed Web of Science ®Google Scholar
• Sun F, Wang J, Pan Q, Yu Y, Zhang Y, Wan Y, et al. Characterization of function and regulation of miR-24-1 and miR-31. Biochem Biophys Res Commun 2009; 380:660 - 5; http://dx.doi.org/10.1016/j.bbrc.2009.01.161; PMID: 19285018
   PubMed Web of Science ®Google Scholar
• Lin Q, Gao Z, Alarcon RM, Ye J, Yun Z. A role of miR-27 in the regulation of adipogenesis. FEBS J 2009; 276:2348 - 58; http://dx.doi.org/10.1111/j.1742-4658.2009.06967.x; PMID: 19348006
   PubMed Web of Science ®Google Scholar
• Kim SY, Kim AY, Lee HW, Son YH, Lee GY, Lee JW, et al. miR-27a is a negative regulator of adipocyte differentiation via suppressing PPARgamma expression. Biochem Biophys Res Commun 2010; 392:323 - 8; http://dx.doi.org/10.1016/j.bbrc.2010.01.012; PMID: 20060380
   PubMed Web of Science ®Google Scholar
• Tang YF, Zhang Y, Li XY, Li C, Tian W, Liu L. Expression of miR-31, miR-125b-5p, and miR-326 in the adipogenic differentiation process of adipose-derived stem cells. OMICS 2009; 13:331 - 6; http://dx.doi.org/10.1089/omi.2009.0017; PMID: 19422302
   PubMed Web of Science ®Google Scholar
• Xie H, Lim B, Lodish HF. MicroRNAs induced during adipogenesis that accelerate fat cell development are downregulated in obesity. Diabetes 2009; 58:1050 - 7; http://dx.doi.org/10.2337/db08-1299; PMID: 19188425
   PubMed Web of Science ®Google Scholar
• Wilfred BR, Wang WX, Nelson PT. Energizing miRNA research: a review of the role of miRNAs in lipid metabolism, with a prediction that miR-103/107 regulates human metabolic pathways. Mol Genet Metab 2007; 91:209 - 17; http://dx.doi.org/10.1016/j.ymgme.2007.03.011; PMID: 17521938
   PubMed Web of Science ®Google Scholar
• Lee EK, Lee MJ, Abdelmohsen K, Kim W, Kim MM, Srikantan S, et al. miR-130 suppresses adipogenesis by inhibiting peroxisome proliferator-activated receptor gamma expression. Mol Cell Biol 2011; 31:626 - 38; http://dx.doi.org/10.1128/MCB.00894-10; PMID: 21135128
   PubMed Web of Science ®Google Scholar
• Yang Z, Bian C, Zhou H, Huang S, Wang S, Liao L, et al. MicroRNA hsa-miR-138 inhibits adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells through adenovirus EID-1. Stem Cells Dev 2011; 20:259 - 67; http://dx.doi.org/10.1089/scd.2010.0072; PMID: 20486779
   PubMed Web of Science ®Google Scholar
• Esau C, Kang X, Peralta E, Hanson E, Marcusson EG, Ravichandran LV, et al. MicroRNA-143 regulates adipocyte differentiation. J Biol Chem 2004; 279:52361 - 5; http://dx.doi.org/10.1074/jbc.C400438200; PMID: 15504739
   PubMed Web of Science ®Google Scholar
• Whittaker R, Loy PA, Sisman E, Suyama E, Aza-Blanc P, Ingermanson RS, et al. Identification of MicroRNAs that control lipid droplet formation and growth in hepatocytes via high-content screening. J Biomol Screen 2010; 15:798 - 805; http://dx.doi.org/10.1177/1087057110374991; PMID: 20639500
   PubMed Web of Science ®Google Scholar
• Kennell JA, Gerin I, MacDougald OA, Cadigan KM. The microRNA miR-8 is a conserved negative regulator of Wnt signaling. Proc Natl Acad Sci U S A 2008; 105:15417 - 22; http://dx.doi.org/10.1073/pnas.0807763105; PMID: 18824696
   PubMed Web of Science ®Google Scholar
• Qin L, Chen Y, Niu Y, Chen W, Wang Q, Xiao S, et al. A deep investigation into the adipogenesis mechanism: profile of microRNAs regulating adipogenesis by modulating the canonical Wnt/beta-catenin signaling pathway. BMC Genomics 2010; 11:320; http://dx.doi.org/10.1186/1471-2164-11-320; PMID: 20492721
   PubMed Web of Science ®Google Scholar
• Nakanishi N, Nakagawa Y, Tokushige N, Aoki N, Matsuzaka T, Ishii K, et al. The up-regulation of microRNA-335 is associated with lipid metabolism in liver and white adipose tissue of genetically obese mice. Biochem Biophys Res Commun 2009; 385:492 - 6; http://dx.doi.org/10.1016/j.bbrc.2009.05.058; PMID: 19460359
   PubMed Web of Science ®Google Scholar
• Iliopoulos D, Drosatos K, Hiyama Y, Goldberg IJ, Zannis VI. MicroRNA-370 controls the expression of microRNA-122 and Cpt1alpha and affects lipid metabolism. J Lipid Res 2010; 51:1513 - 23; http://dx.doi.org/10.1194/jlr.M004812; PMID: 20124555
   PubMed Web of Science ®Google Scholar
• Kinoshita M, Ono K, Horie T, Nagao K, Nishi H, Kuwabara Y, et al. Regulation of adipocyte differentiation by activation of serotonin (5-HT) receptors 5-HT2AR and 5-HT2CR and involvement of microRNA-448-mediated repression of KLF5. Mol Endocrinol 2010; 24:1978 - 87; http://dx.doi.org/10.1210/me.2010-0054; PMID: 20719859
   PubMed Web of Science ®Google Scholar
• Sun T, Fu M, Bookout AL, Kliewer SA, Mangelsdorf DJ. MicroRNA let-7 regulates 3T3-L1 adipogenesis. Mol Endocrinol 2009; 23:925 - 31; http://dx.doi.org/10.1210/me.2008-0298; PMID: 19324969
   PubMed Web of Science ®Google Scholar
• Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008; 18:997 - 1006; http://dx.doi.org/10.1038/cr.2008.282; PMID: 18766170
   PubMed Web of Science ®Google Scholar
• Zampetaki A, Kiechl S, Drozdov I, Willeit P, Mayr U, Prokopi M, et al. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res 2010; 107:810 - 7; http://dx.doi.org/10.1161/CIRCRESAHA.110.226357; PMID: 20651284
   PubMed Web of Science ®Google Scholar
• Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 2008; 105:10513 - 8; http://dx.doi.org/10.1073/pnas.0804549105; PMID: 18663219
   PubMed Web of Science ®Google Scholar
• Stenvang J, Kauppinen S. MicroRNAs as targets for antisense-based therapeutics. Expert Opin Biol Ther 2008; 8:59 - 81; http://dx.doi.org/10.1517/14712598.8.1.59; PMID: 18081537
   PubMed Web of Science ®Google Scholar
• Czech MP, Aouadi M, Tesz GJ. RNAi-based therapeutic strategies for metabolic disease. Nat Rev Endocrinol 2011; 7:473 - 84; http://dx.doi.org/10.1038/nrendo.2011.57; PMID: 21502982
   PubMed Web of Science ®Google Scholar
• Ebert MS, Neilson JR, Sharp PA. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods 2007; 4:721 - 6; http://dx.doi.org/10.1038/nmeth1079; PMID: 17694064
   PubMed Web of Science ®Google Scholar
• Gumireddy K, Young DD, Xiong X, Hogenesch JB, Huang Q, Deiters A. Small-molecule inhibitors of microrna miR-21 function. Angew Chem Int Ed Engl 2008; 47:7482 - 4; http://dx.doi.org/10.1002/anie.200801555; PMID: 18712719
   PubMed Web of Science ®Google Scholar